The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice
Coronavirus (Covid-19) — NEJM
Fixing Burnout Through Physician Input
We Can Do Better — Improving the Health of the American People | NEJM
NEJM — Race and Medicine
About NEJM
Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM
Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma | NEJM
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation | NEJM
Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018 | NEJM
Implanted System for Orthostatic Hypotension in Multiple-System Atrophy | NEJM
Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media | NEJM
The impact factor for leading international journals. JAMA: Journal of... | Download Scientific Diagram
The New England Journal of Medicine: Research & Review Articles on Disease & Clinical Practice
The New England Journal of Medicine - The new impact factor for NEJM is 54.42 (up 5%). Thank you to all of our authors, and to all of the patients who participate
At NEJM, change at top offers chance to reshape the world's oldest medical journal
Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM
2 021 NEJM Group U.S. Media Kit
The Future of Public Health | NEJM
Perspective: The intersection of public health and clinical medicine is changing | News | Harvard T.H. Chan School of Public Health
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
Understanding and Mitigating Health Inequities — Past, Current, and Future Directions | NEJM
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
The world's top medical journals
New England Journal of Medicine on Ovid | Wolters Kluwer
Long-Term Complications in Youth-Onset Type 2 Diabetes | NEJM
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
